Introduction
Female lower urinary tract symptoms: pharmacotherapeutic consequences
Novel role for α 1 -adrenergic receptor subtypes in lower urinary tract symptoms
α-Blockers and lower urinary tract function: more than smooth muscle relaxation?
Clinical pharmacology of α 1A selective and nonselectiveα 1 -blockers
New roles for muscarinic receptors in the pathophysiology of lower urinary tract symptoms
Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin
Summary of the meeting